Li, H., Li, M., Yang, L., Lu, T., Zhao, Z., Hu, Y., . . . Shi, C. Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. BMJ Publishing Group.
Chicago Style (17th ed.) CitationLi, Hui, et al. Inhibition of Stromal MAOA Leading Activation of WNT5A Enhance Prostate Cancer Immunotherapy by Involving the Transition of Cancer-associated Fibroblasts. BMJ Publishing Group.
MLA (9th ed.) CitationLi, Hui, et al. Inhibition of Stromal MAOA Leading Activation of WNT5A Enhance Prostate Cancer Immunotherapy by Involving the Transition of Cancer-associated Fibroblasts. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.